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Abstract 
This paper examines the development of clinical pathways in a hospital in Australia based on empirical 
clinical data of patient episodes. A system dynamics (SD)-based decision support system  is developed and 
analyzed for this purpose. The study highlights the scenarios that will help hospital administrators to 
redistribute caseloads amongst admitting clinicians with a focus on multiple Diagnostic Related Groups 
(DRG’s) as the means to improve the patient turnaround and hospital throughput without compromising 
quality patient care.  DRG’s are the best known classification system used in a casemix funding 
model.  Casemix is a DRG-based government funding model for hospitals with a mix of performance 
measures aiming to reward initiatives that increase efficiencies in hospitals. The classification system 
groups inpatient stays into clinically meaningful categories of similar levels of complexity that consume 
similar amounts of resources. Policy explorations reveal various combinations of the dominant policies that 
hospital management can adopt. With the use of visual interfaces, executives can manipulate the DSS to 
test various scenarios. Experimental evidence based on focus groups demonstrated that it can enhance 
group learning processes and improve decision making. The  findings are supported by other recent studies 
of clinical pathway implementation on various DRG’s. These showed substantial reduction in length of 
stay, costs and resource utilization. 
Running Head: “System Dynamics Study for Clinical Pathways in a Hospital” 
Keywords: Clinical Pathways (CP), System Dynamics (SD), Decision Support System (DSS), Diagnostic 
Related Groups (DRG) 
Introduction 
 
The techniques associated with the traditional hospital turnaround - although still important - are not 
sufficient for achieving and sustaining positive performance. These results are usually symptomatic of 
multiple problems throughout the organization, such as weak or dysfunctional management, failed or 
inadequate medical staff strategies, uncompetitive costs, weakened market position, or failed strategies. 
Cost reduction policies produce such phenomena directly because of loss of staff and decreased efficacy of 
care, and indirectly when these problems cause loss of patient population and overall higher per capita 
costs. A simulation approach offers hospital policy makers a hands-on way to experience a number of these 
archetypal phenomena.   
 
The study described was based upon work with Australian data. Here the notions of “profit” and “markets” 
are not uncommon and this contrasts somewhat with a publicly-financed system, free at the point of use, 
such as is found in the National Health Service in the United Kingdom. 
 
Historically, most of the solutions to hospital turnarounds can be found within the institution itself. By 
initiating dramatic cuts in expenses, involving clinicians, maximizing revenue and cash flow, attempting to 
increase volume, improving market position, and other "tried-and-true" techniques, hospitals can turn 
themselves around and maintain profitability.  
 
The key trends identified in this research study point to declining in-patient utilization and revenues with 
average hospital occupancy of less than 60%. The hospital is therefore carrying debt for beds that are not 
being used. Many hospital boards have been caught by surprise because they did not understand how fast 
patient days and revenue could decrease in their market, or because volume assumptions were just wishful 
thinking, not supported by market realities or even the hospital's own trends. 
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One of the key strategic business decisions in a hospital, that could significantly alter the trajectory of the 
hospital towards “best clinical practices” and healthy surpluses, is the establishment of a Clinical Pathways 
(CP) Policy. Clinical Pathways describes the usual way of providing multidisciplinary care for a particular 
type of patient and allows annotation of deviations from the norm for the purpose of improvement (Hindle, 
1998). The Australian Health Legislation Act also requires contracts between health funds and hospitals to 
be described on the basis of the Australian National Diagnostic Related Groups. This enables hospital 
managers to undertake medical treatment costs variance analysis.  
 
Clinical pathways can provide reasons for variance and empower management to redress the system. 
Analysis of individual clinician variance could possibly result in suggestions for changes in care, economic 
punitive action (such as withdrawal of accreditation), or demands that a clinical pathway be adhered to as a 
condition of future accreditation or agreement between clinician and hospital. With a system dynamics 
(SD)-based simulation model (Sterman, 2000), it is possible to understand the “most cost effective clinical 
practice” within the hospital for a particular DRG profiled against the national benchmarks for that DRG. 
 
Literature 
 
Medical research findings are slow to change medical opinion and practice (Phillips, 1998). Empirical 
studies have shown that on average, there is an 8—13 year time lag (depending on the specialty) between a 
treatment being proven to work and its adoption as standard practice. It has also been found that 70% of 
treatments currently in use do not have sufficient evidence to support that they are any more effective than 
doing nothing (Chalmers, 1993). One of the major barriers to the implementation of research findings is the 
volume and geometric growth of the medical literature. It is not humanly possible to keep up with all the 
advances in all areas of medical research (Jordens et al, 1998). It is also difficult for medical practitioners 
to make sense of the often-conflicting research findings in a particular area. 
 
Recognition of such problems led to the discipline of evidence based medicine (EBM). The aim of EBM is 
to bring research and practice closer together and reduce the time lag between the development of clinically 
proven treatments and their use in everyday medical practice as clinical pathways. 
 
The medical profession’s approach to unexplained clinical variation in treatment practices understandably 
leads to the undesirable side effect of cost increases. The hospital executives involved in this research study 
explained that the introduction of clinical pathways as practice guidelines in some DRG’s would reduce by 
30% percent the variation in clinician practice patterns for cases without clinical complications or co-
morbidities. The clinical variance for 1998 in the hospital under study was estimated at 200%. Emerging 
literature on clinical pathways shows how their use contributes to improving the appropriateness and 
integration of care and its outcomes, lowering complication and infection rates, improving patient 
participation and satisfaction and achieving better resource utilization (Ellrodt et al. 1995; Holt et al. 1996; 
Leape, 1990; Lomas, 1989; Thomson et al 1995). 
 
Studies in the University of Pennsylvania Health System (Guadagnino, 1998) which implemented 30 
clinical pathways (for conditions such as hysterectomy, asthma, bone marrow transplant, carotid 
endarterectomy, colectomy, craniotomy, cystic fibrosis, gastro-intestinal bleed, hip and knee replacement, 
low birth weight infants, pneumonia and liver transplants) found that clinician resistance and collection of 
variance information vis-à-vis the pathways were formidable issues. 
 
 
Model Structure & Development 
 
Five hospital focus group members were actively involved in the model development process. The focus 
group, which included two clinicians, helped the author to identify the key trails in the flows of patients and 
monetary transactions taking a “process-orientated” view through the organization (Vissers and Beech, 
2005). In order to understand hospital throughput and contributing drivers to workload it is necessary to 
understand the linkages between patient referrals, clinician interactions, hospital performance and costs. A 
visual walkthrough of the business processes was also conducted. A more complex model was developed 
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during the workshops for the Clinician & Patient Market, Clinical Governance, Financial Management and 
Hospital Management domains.  
 
The knowledge elicited and relationships between the players are identified in figures 1 and 2 below 
(Maliapen, 1998a). Table 1 provides the details of these identified relationships as linkage vectors 
indicating the reinforcing (S–same direction) or opposing (O-opposite direction) behavior. In figure 1 
information linkages are illustrated as dotted lines in the dynamic hypotheses and delays in response to 
actions have been indicated where appropriate. Linkages with continuous black lines indicate the flow of 
resources such as cash or patients within the organization (also figure 1). As regards figure 2 the bolder 
continuous loops indicate the existence of feedback loops and these are labeled (B) for balancing loops and 
(R) for reinforcing loops.  The relationships in model structure were developed based upon the experience 
of hospital professionals, researched literature references and evidence of documented hospital practices.  
 
Despite clinicians’ consternations, the hospital’s efforts to standardize clinical practices have gradually 
intensified over the last few years. There were 7372 inpatient admissions spread across 13 DRG’s and 
casemix data analysis showed that in at least eight of these DRG’s there were 30 or more different 
clinicians involved per DRG over the year. Workshop participants agreed that the volume of cases treated 
per clinician and the associated DRG’s per Clinician was low. The number of adjacent DRG’s treated in the 
same specialty; in 43 % of the cases analyzed were only 2 per clinician while 40 % of clinicians treated 
single DRG’s. Both these factors were considered to significantly impact the level of entropy and 
dispersion in the hospital system with 13 DRG’s being treated by 132 clinicians (Table 1, link 4 & 7). 
 
Participants stated that the range of DRG’s and the volume of cases treated per clinician at the hospital had 
a tremendous impact on the services contribution of the clinician to the hospital. The services contribution 
is numerically equivalent to the product of the cost weight and the clinician caseload for each DRG. Under 
the casemix system, hospitals are paid for treatment to patients based on the cost weight which is the 
relative time each patient stays in hospital compared to other patients with similar conditions and the 
relative cost of treating their condition compared to the cost of other illnesses. In general, hospital 
management tends to regard revenue contributions from “high volume” DRG clinicians as “sustainable 
income streams” and critical to the hospital financial position. Hospital management tend to balance the 
reluctance of clinicians towards “performance measurement”, much needed for clinical pathways, with 
measures to retain their services through incentives and higher satisfaction levels. Participants mentioned 
that attrition of these clinicians would erode their profit margins hence a desire to reduce low volume 
clinicians is important (Table 1, link 6). 
  
Clinical governance in acute care settings is a further indication of the increasing concern about clinician 
accountability and about efficiency and effectiveness of hospitals as the core units of the health care system 
(Secretary of Health, 1997; Scally and Donaldson, 1998; Lugon and Secker-Walker, 1999). The twin aims 
of improving clinical effectiveness and hospital efficiency are interpreted as signaling a substantial 
extension of management into clinical preserves, particularly in respect of resource use implications of 
clinical practice and the profession’s claimed right to self -regulation. 
 
 
Medicare
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Figure 1: SD Model Structure for  Clinical Governance 
Pathways could speed up treatment regimens by flagging therapies at appropriate intervals and including 
drug plans that rein in costs (e.g. brands of medication or prostheses) attributed to discretionary prescription 
habits across clinicians (Table 1, link 24). The issues of clinician compliance to performance measurement 
and clinician satisfaction are interdependent (Table 1, links 8 & 15). Hospital executives suggested that 
better compliance behavior can be achieved with the use of education, clinical opinion leaders, peer review, 
feedback of patient data, administrative interventions and incentives (both financial and non financial). Of 
these, literature review supports the financial incentives as the most effective tool to achieve compliance 
behavior. (Table 1, link 14) (Dickinson et. al.,1999). 
 
Given that the average length of stay for each DRG remains unchanged, then as the volume of hospital 
admissions increases, the bed occupancy of the hospital rises. As a workload driver, increased bed 
occupancy increases the workload of clinicians, the hospital’s nursing and medical staff but inadvertently 
reduces their span of attention per patient. The possibility of lengthening the patient’s hospital stay to cope 
with the increasing workload is a natural side effect to improve treatment. The resulting quality of care has 
an impact on patient satisfaction. An adverse level in the quality of care over many patients has a delayed 
effect on clinician referrals and consequently impacts the clinician’s future caseload. 
 
Medical and nursing staffing mix will determine the clinician/medical team staff ratio and co-operation 
levels (Table 1, link 14). With higher case volumes (link 22) and movement in staff rosters, shifting 
workload demands affect the availability of staff for better patient care management, which consequently 
impacts the quality of care and patient satisfaction during the hospital stay. The clinician’s reputation and 
experience naturally determines his command of the market share, not to mention that the skills for treating 
multiple DRG’s will increase demand for the clinician’s services. 
 
 
Table 1: Clinical Governance Loops and Links  
Links Vector 
(S/O) 
Linkage Description 
 
Input Link                      Output 
Link 
Comments  
1 S Hospital Clinician 
Caseload 
Hospital 
Admissions 
 
2 O Hospital Clinician 
Caseload 
Clinician 
Quality of Care 
Information Link 
3 O Desire to minimize 
Low Volume 
Clinicians  
Clinician 
Compliance to 
Performance 
Measures 
Information Link & 
Delay 
4 S No of DRG’s 
treated by 
Clinician 
Desire to 
minimize Low 
Volume 
Clinicians 
 
5 S Hospital 
Admissions 
Occupancy  
6 S Low Volume 
Clinician Fraction 
Desire to 
minimize Low 
Volume 
Clinicians 
 
7 S Hospital 
Admissions 
Low Volume 
Clinician 
Fraction 
 
8 O Clinician 
Compliance to 
Performance 
Measures 
Hospital 
Clinician 
Caseload 
Information Link 
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Links Vector 
(S/O) 
Linkage Description 
 
Input Link                      Output 
Link 
Comments  
9 S Clinician 
Compliance to 
Performance 
Measures 
Change in 
Productivity 
Information Link 
10 O Change in 
Productivity 
Clinician 
Satisfaction 
Information Link 
11 S Fees Relative to 
Medicare 
Clinician 
Satisfaction 
Information Link 
12 O Clinician 
Satisfaction 
Hospital 
Clinician 
Caseload  
Information Link 
13 O Clinician-Hospital 
Medical Team 
Cooperation Ratio 
Clinician 
Satisfaction 
Information Link 
14 S Hospital Clinician 
Caseload 
Clinician-
Hospital 
Medical Team 
Cooperation 
Ratio 
 
15 O Ave Clinical 
Pathways 
Clinician 
Satisfaction  
Information Link 
16 O Ave Clinical 
Pathways 
Hospital 
Clinician 
Caseload 
Information Link 
17 O Hospital Clinician 
Caseload 
Proportion of 
Caseload 
Admitted to 
Other Hospitals 
 
18 O Fees Relative to 
Medicare 
Patient 
Satisfaction 
Information Link 
19 O Clinician Quality 
of Care 
Repeat 
Episodes 
Information Link 
20 O Repeat Episodes Patient 
Satisfaction 
Information Link 
21 S Clinician-Hospital 
Medical Team Co-
operation Ratio 
Patient 
Satisfaction 
Information Link 
22 S Clinician-Hospital 
Medical Team Co-
operation Ratio 
Flexibility of 
Deployment 
Information Link 
23 S Rate of Pathways Ave Clinical 
Pathways 
 
24 S Desire to minimize 
medical variations 
Rate of Clinical 
Pathways  
 
25 S Desire to minimize 
Low Volume 
Clinicians 
Change in 
Productivity 
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Figure 2: Causal Loop Analysis for Clinical Governance (Note: PCH & PMH are acronyms 
associated with the hospital and unit involved; LOS is Length of Stay) 
 
Model Evaluation 
 
The study participants were interviewed to investigate their perceptions about learning and applying the SD 
models for decision-making. Issues investigated during interviews include: the understanding of the model 
design and its purpose; the value of the visual user interface to the decision maker and its contribution to 
understanding the model structure; the decision maker’s learning curve with the visual interface (VI); the 
impact of the VI on decision making; the benefits and the perceived advantages of SD-based VI models. 
 
A questionnaire, consisting of 40 questions was developed to probe hospital managers' views of SD-based 
VI models. The questionnaire was applied to the 5 focus group members and the 30 participants 
independently. All respondents were provided the questionnaires 2 weeks prior to the interviews. The focus 
group was regarded as the reference group of model-builders’ as they are involved in all phases of model 
development, evaluation and analysis. 
 
The responses were analyzed in a descriptive fashion across four dimensions namely model characteristics, 
manipulation, evaluation and performance. The differences between the focus group members’ responses 
and the hospital managers' responses were determined. The similarity in the responses helped build 
confidence that the views of other managers within the hospital population were consonant with the views 
of the focus group towards SD-based VI models. 
 
Reference Mode and Baseline Model  
 
The reference mode was fundamental to model structure evaluation - for the purposes of discovering 
patterns and sensitivity analysis, simulation of multiple policies and scenarios. The model was 
parameterised for the situation before clinical pathways were introduced so as to provide a benchmark 
against which to compare the CP implementation. The model was tested against two years of historical 
casemix data using actual patient arrival patterns. It produced acceptable error rates in forecasting historical 
financial performance, bed occupancies and seven other key performance indicators. Clinicians and 
hospital administrators validated the model responses in the case study and compared the simulated results 
against the Actual Financial Performance - called the Reference Mode. 
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However, it needs to be pointed out that occurrence of events in the past alone cannot be interpreted to 
mean that events in the future will follow accordingly. While both historical financial behavior and a 
reference mode can be expressed in either quantitative or descriptive terms, a reference mode is essentially 
a qualitative and intuitive concept since it represents a pattern rather than a precise description of a series of 
events (Saeed, 1998). A reference mode also subsumes past history, extended experience and a future 
inferred from projecting the inter-related past trends based on the experience of the experts. A reference 
mode will also not contain random noise normally found in historical trends, as noise represents a problem 
behavior rather than the system behavior. The caveat is with the exclusive use historical casemix data to 
construct the reference mode. 
 
Simulation Analysis & Results  
 
The clinical pathways policy is also the result of hospital management’s desire to reduce medical errors and 
deviations in clinical practice and also to reduce the number of clinicians with low case volumes. Each 
DRG or disease group has its own pathway documenting the details of the recommended procedures, 
expected patient outcomes, pharmaceuticals, clinical investigations, prognosis monitoring and 
instrumentation for the surgical procedure. The formalization of pathways in any hospital environment is 
tedious and a challenging implementation which requires many hours of education, protocol explanation, 
monitoring and control against targets. There are benefits for such a long-term view as this clinical 
methodology introduces standardization in medical practice. 
 
In the simulation results reported below the run time is 104 weeks. The two year time horizon for the 
simulation modeling was considered adequate and reasonable by the hospital executives and clinicians who 
participated in this study. The initial values of hospital costs are negative followed by a subsequent ramp up 
which is a fluctuation inherent in the data reflecting the volume of patients being treated at that point in 
time. 
 
In the simulation model, the desire to minimize the number of clinicians with low practice volumes is 
management’s central objective. In applying the CP policy, it was decided that patient admissions be held 
constant throughout the experimentation with the pathway variables such as the rate of CP implementation, 
the desire to minimize medical procedure deviations and the level of pathways arrayed across the DRG’s. 
A switch in the simulation model labeled ‘Clinical Governance Policy’ maintains the same patient volume 
to allow experimentation with the effectiveness of CP policies. 
 
One significant simulation result demonstrates (Figure 3) that hospital costs decrease with increased CP 
implementation. Such a policy allows a potential increase in capacity to treat more patients (described by 
variations in occupancy) resulting from the overall reductions in lengths of stay (due to adherence to 
recommended CP procedures). This is reflected in loop LB4 in figure 2. In Figure 3, Plot 3 and 4 show 
some oscillations. The oscillations are an indication of the hospital’s dependence on a few “admitting” 
clinicians for DRG G45B – Gastroscopy – and seem to indicate that admission numbers fluctuated until the 
patients became aware that low volume clinicians no longer had admitting rights to the hospital for this 
DRG. It requires 18 months to arrive at a near steady upward trend. The “ramp up” of net hospital costs in 
the initial weeks is due to negative start-up costs in the simulation data. 
 
The different levels of clinical pathways across the DRG’s are shown in Figure 4. This graph plots the 
effectiveness of CP policy implementation. The qualitative linear scale of CP is from 0-1000 with no CP 
implemented at the zero end and full CP implemented at the upper end of the scale. It is clear that the 
model represents hospital management’s desire to reduce clinical and treatment variances relative to the 
divergent number of clinicians practicing at the hospital. Clinical treatment variations from a large number 
of clinicians dissipate the efforts of the clinical pathways policy to streamline clinical practices. The 
number of practicing clinicians for DRG G45B (Gastroscopy) was reduced to test this policy. A smaller 
and more manageable group of clinicians with focus on implementing the CP system would bring better 
benefits to the organization.  
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(Plot 1 – No CP implemented;  Plot 2- CP implemented;  Plot 3- No CP implemented 
but with reduction of low volume  clinicians in DRG G45B;  Plot 4 – CP implemented 
with a reduction of low volume  clinicians in DRG G45B) Y-axis Net Hospital Costs in 
AUD$ 
Figure 3: Clinical Pathways Policy – Net Hospital Costs Var iation (G45B = Gastroscopy)  
 
 
 
 
(Plot 1 – No CP implemented;  Plot 2- CP implemented;  Plot 3- No CP implemented 
but with reduction of low volume  clinicians in DRG G45B;  Plot 4 – CP 
implemented with reduction of low volume clinicians in DRG G45B) – Y-axis scale 0 
– no CP implemented and 1000 – Full CP implemented 
Figure 4: Clinical Pathways Policy – Mean CP Level (G45B= Gastroscopy)  
 
It is also worth noting that the overall bed occupancy of the hospital peaked much earlier in week 79 
(Figure 5; Plot 1) than, for the same volume of patients, the actual performance reported over two years. 
This finding reveals that the experimentation with various CP implementation strategies can lead to early 
saturation of capacity, simultaneously achieving operational efficiency. Hospital management indicated 
that, from their experience, CP implementation actually has a regulatory effect on the use of shared 
resources within the hospital. 
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(Plot 1- Simulated Occupancy, Plot 2 – Actual Occupancy) 
Figure 5: Clinical Pathways Policy – Bed Occupancy (% ) 
 
The variations in bed occupancies enable the treatment of more patients, a side effect of overall shorter 
lengths of stay and more efficient clinical care. This desired effect from CP implementation is shown in 
Figure 6 for each of the simulations. The Sum of Variations in Figure 6 is the weekly average of daily bed 
occupancies. The explanation for oscillations in Plots 3 and 4 in Figure 6 is due to the fluctuations in 
admission numbers when low volume clinicians are removed as in Figure 3. 
 
 
 
(Plot 1 – No CP implemented;  Plot 2- CP implemented;  Plot 3- No CP 
implemented but with reduction of low volume  clinicians in DRG G45B;  Plot 4 – 
CP implemented with a reduction of low volume  clinicians in DRG G45B) 
Figure 6: Clinical Pathways Policy – Var iations in Bed Occupancy in %  (G45B= Gastroscopy)  
 
The quality of care is measured on a relative qualitative scale from 0-1, where 1 is the most desired 
outcome for quality. Its importance in the simulation modeling process is to help hospital executives assess 
the values of quality in relation to each other across different model iterations A notable and desirable 
consequence of the CP implementation is the  increase in quality of care, even though it is delayed until 
week 82 (Figure 7; Plot 4) The delayed effect of the CP on quality was explained by hospital executives as 
a latent result of the reduction of errors in diagnosis and treatment due to implementation of CP being 
monitored. The full implementation of CP is the result of organizational and cultural changes in attitudes 
on the part of clinicians and nurses, with greater due diligence in patient management and care. 
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A study to determine the effects of clinical pathway implementation on patients undergoing elective 
pancreaticoduodenectomy (PD) on cost and resource utilization concluded that the establishment of a 
clinical pathway for PD patients dramatically reduced costs and resource utilization. It had no apparent 
detrimental effect on quality of patient care. These current findings support the implementation of clinical 
pathways for PD patients, as well as investigation into pathway care for other complex surgical procedures. 
(Porter et al, 2000). The evidence of these latter findings is consistent and supports our CP model 
simulation studies. 
 
 
 
 
(Plot 1 – No CP implemented Plot 2- CP implemented; Plot 3- No CP 
implemented but with reduction of low volume clinicians in DRG G45B; Plot 4 – 
CP implemented with reduction of low volume clinicians in DRG G45B) 
Figure 7: Clinical Pathways Policy – Quality of Care (DRG G45B= Gastroscopy) 
 
 
 
 
(Plot 1 – No CP implemented;  Plot 2- CP implemented; Plot 3- No CP 
implemented but with reduction of low volume  clinicians in DRG G45B; Plot 4 – 
CP implemented with reduction of low volume  clinicians in DRG G45B) 
Figure 8: Clinical Pathways Policy – Hospital Cashflow (DRG G45B= Gastroscopy) Units= AUD$ 
 
Finally, the CP implementation results in an increase in cashflow less the cost of CP implementation 
(Figure 8). The main driver for this is the “revolving door” effect that allows more patients to be admitted 
and treated due to the faster turnaround by the hospital. The comparison of plots 1 & 2 with plots 3 & 4 
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separately in Figure 8 merely reflects that the reductions in low volume clinicians for DRG G45B did not 
have any significant impact on cashflow since their patient volume is low. 
 
Discussion  
 
The lessons for clinicians, which is supported with simulation and interview results, suggest that factors 
such as the excessive specialization, the lack of flexibility between medical teams, the absence of 
champions supporting systematic clinical pathways and the level of integration between nursing and 
medicine are likely to cause serious disruptions to hospital performance. Clinicians agreed that there was 
currently little evidence of multi-disciplinary clinical production-focused teams at the hospital. The absence 
of a clinical production focus as a key building block for hospital management and the pre-occupation with 
input management at all levels are potential areas for clinicians to co-operate with hospital managers.  
 
Clinicians also agreed that the untoward dispersion of patients across multiple wards; the individualism of 
their profession; the marginality of nursing perspectives in the organization and management of clinical 
work; and the absence of structures, practices and processes (at the clinician level) oriented to bringing 
clinical work under control such as clinical pathways needed attention. The lessons learned suggest that 
clinicians be allowed to participate in operating assumptions, admissions and utilization forecasts, financial 
performance, return-on investment calculations, governance and organization, marketing and promotion 
plans, implementation of strategic initiatives and share responsibilities. 
 
Capitation and other risk models of reimbursement change the focus of strategic hospital management from 
patient admissions to “managing clinical resources”. Clinical resource management represents the ability to 
reduce the cost per episode in line with competitors. Clinical governance as explicitly addressed in the 
simulation models means providing quality patient care with the least amount of resources. It means not 
only continuing to reduce length of stay, medical deviations and errors, but also reducing use of ancillary 
services while the patients are in hospital. 
 
In 2003, a study on the effectiveness of CP in the management of Congestive Heart Failure (CHF) 
concluded that “the clinical pathway for CHF was associated with increased use of ACE inhibitors and it 
resulted in a reduced length of stay and hospital charges” (Ranjan, 2003) 
 
Also our simulation model findings on cost and quality improvements associated with CP have been 
validated independently in a study at Department of Neurosurgery, University of Duisburg-Essen and their 
conclusions are stated as follows: “Clinical pathways can merge the interests of people with a medical and 
an economical background in order to improve treatment quality and to enhance cost-structures of complex 
treatments. The current data demonstrates that the higher initial expenditure of acquiring a neuronavigation 
system will be indirectly reimbursed as it decreases the overall treatment costs” (Jung et.al, 2007) 
 
The importance and significance of clinical pathways has been emphasised in this study. The hospital has 
to be selective in developing critical pathways (standard protocols) for treatment of high volume DRG’s. 
The development of clinician practice profiles or signatures that identify how the major specialty groups 
are performing on the basis of their length of stay and cost per discharge, benchmarked against outcomes 
compared to peers, other facilities in the market and to national databases, is a vital lesson for policy 
makers. The same clinical data can be used to create a global contracting model for key services, such as 
hip replacement, open-heart surgery, stroke management, and other services common to a hospital. 
Hospital policy makers can apply these non-traditional polices amongst the profession to enhance revenue 
and reduce low DRG volume clinicians. In a more recent publication Cardoen and Demeulemeester (2007) 
reveal that a discrete event simulation model the research team developed was deployed in hospitals in 
Antwerp. It enabled the health manager to evaluate and improve performance indicators such as capacity 
of, and patient flow along, clinical pathways, to the benefit of both the patient and the hospital. 
 
The hospital can use the simulation model to create “DRG based profitability analysis” that identifies those 
inpatient and out- patient services with positive and negative bottom lines. Policy makers can then plan for 
program elimination, subsidization, or expansion based on shared inputs from clinicians.  
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Conclusions 
 
The study has shown that a system dynamics based decision support tool was instrumental in enabling 
hospital managers and clinicians jointly to review the possibilities for implementation of clinical pathways. 
Streamlining the clinical practices with appropriate clinical pathways amongst the high volume DRG’s will 
reduce treatment costs significantly. But introducing these without dealing with critical inefficiencies such 
as low-volume DRG’s is not recommended. The casemix simulation model suggests that the hospital 
management should refine the admitting rights policy to replace “low volume” and multiple DRG’s 
clinicians with “high volume DRG’s” clinicians in conjunction with the implementation of clinical 
pathways.  If this is not accomplished then the larger number of clinicians involved dissipates the effort of 
the clinical pathways policy to streamline clinical practices. 
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